UPClytics
View all cases

UPC CoA 23/2026

Feb 12, 2026·EP2493466 · NOVEL ANTITUMORAL USE OF CABAZITAXEL

Case details
Status
Deliberation Phase
Action
Appeal
Category
Main appeal
Parties
Claimants
Representatives
Respondents
Representatives
Division
Court of Appeal
Technology
  • Chemistry
    Pharmaceuticals
Language
English
EPO Opposition
How this compares
How long the court takes to reach a first decision.
Median days to first decision
All UPC124
Judge Rian KaldenLocked
Judge Ingeborg SimonssonLocked
Judge Patricia RombachLocked
Judge Oliver WernerLocked
Judge Xavier Dorland-GalliotLocked

At the UPC: Sanofi Group (33 cases)·Reddy Pharma SAS (8 cases)

This dispute contains 7 other proceedings

UPC CoA 26/2026·UPC CFI 92/2026·UPC CFI 374/2024·UPC CFI 147/2024·CC 49716/2024 and 2 more

10 other defendants litigating the same or a related patent

UPC CoA 22/2026·UPC CoA 24/2026·UPC CoA 25/2026·UPC CoA 27/2026·UPC CFI 496/2024 and 5 more

Start a free trial to see how each one ended.

More cases: Court of Appeal·2026

Document titleDatePublic
Deliberation opened2026-10-08Not public
Oral procedure closed2026-10-08Not public
Hearing recording reference document2026-10-07Not public
Hearing recording reference document2026-10-07Not public
Order2026-10-01Not public
Order2026-10-01Public
Receipt2026-09-23Not public
Cover sheet2026-09-23Not public
Other document Appellant2026-09-23Not public
Oral procedure opened2026-08-12Not public